DCX (O43602) variants and mutations
DCX (also known as O43602) is a human protein-coding gene encoding a neuronal migration protein doublecortin protein. It stabilizes microtubules in migrating neurons and is required for orderly cortical layering during brain development. Loss-of-function variants cause X-linked lissencephaly in males and subcortical band heterotopia in many heterozygous females. This analysis covers 668 DCX variants and mutations. Of these, 60% have computational variant effect predictions. Disease context includes lissencephaly type 1 due to doublecortin gene mutation, subcortical band heterotopia, and Non-syndromic cerebral malformation due to abnormal neuronal migration. Example DCX variants include M1T, E2K, and L3F.
Variant analysis overview
- Gene: DCX
- Protein: O43602
- UniProt accession: O43602
- Organism: Homo sapiens
- Variants analyzed: 668
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 471 unspecified-consequence records; 2 frameshift variants; 108 synonymous variants; 74 missense variants; 3 stop-gained variants; 2 in-frame deletions; 6 splice-region variants; 2 substitution
- Prediction scores: 403 variants have prediction scores (60% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: lissencephaly type 1 due to doublecortin gene mutation, subcortical band heterotopia, Non-syndromic cerebral malformation due to abnormal neuronal migration, Abnormal cortical gyration, hereditary disease, lissencephaly spectrum disorders, Lissencephaly, neurodevelopmental disorder, Abnormal cerebral morphology, Abnormality of the nervous system, fucosidosis, Intellectual disability.
Protein structure and variant hotspots
- Protein features: 2 domains; 25 post-translational modification sites.
- Structural context: 318 variants have structural context.
- PTM context: 42 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable DCX variants
Examples include M1T, E2K, L3F, L3L, H7Y, F8C, F8F, D9Y. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1T (p.Met1Thr), rs587783539, ClinGen CA171917, ClinVar RCV000145831, MetaLR 0.10, MetaSVM -0.99, Pathogenic
- E2K (p.Glu2Lys), rs2524860121, ClinGen CA414247340, ClinVar RCV003560297, Uncertain significance, not provided
- L3F (p.Leu3Phe), NCI-TCGA Cosmic COSV5757, cosmic curated COSV57571, CADD 25.20, PolyPhen-2 0.64, Variant assessed as somatic; moderate impact.
- L3L (p.Leu3Leu), rs1928607563, gnomAD X-111410390-A-G, CADD 12.50
- H7Y (p.His7Tyr), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, Variant assessed as somatic; moderate impact.
- F8C (p.Phe8Cys), gnomAD rs1205084659, CADD 27.60, PolyPhen-2 1.00
- F8F (p.Phe8Phe), rs764063952, gnomAD X-111410375-A-G, CADD 13.90
- D9Y (p.Asp9Tyr), NCI-TCGA Cosmic COSV5756, cosmic curated COSV57569, Variant assessed as somatic; moderate impact.
- D9D (p.Asp9Asp), rs1928606286, gnomAD X-111410372-G-A, CADD 8.75
- E10K (p.Glu10Lys), NCI-TCGA Cosmic COSV5756, cosmic curated COSV57567, Variant assessed as somatic; moderate impact.
- R11T (p.Arg11Thr), Ensembl rs2147276757
- D12G (p.Asp12Gly), rs2147276738, ClinGen CA414247261, ClinVar RCV002276230, NCI-TCGA TCGA novel, CADD 28.60, PolyPhen-2 0.71, Uncertain significance, not provided
- D12N (p.Asp12Asn), cosmic curated COSV57570, CADD 22.70, PolyPhen-2 0.19
- D12L (p.Asp12Leu), rs762964834, []
- K13N (p.Lys13Asn), NCI-TCGA Cosmic COSV5756, cosmic curated COSV57569, Variant assessed as somatic; moderate impact.
- T14A (p.Thr14Ala), cosmic curated COSV10523
- T14T (p.Thr14Thr), gnomAD X-111410357-T-G, CADD 12.90
- S15C (p.Ser15Cys), Ensembl rs748810643, CADD 23.90, PolyPhen-2 0.57
- S15F (p.Ser15Phe), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, CADD 22.80, PolyPhen-2 0.17, Variant assessed as somatic; moderate impact.
- S15P (p.Ser15Pro), rs760302851, []
- R16G (p.Arg16Gly), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, Variant assessed as somatic; moderate impact.
- R16K (p.Arg16Lys), gnomAD rs1293327142, CADD 24.90, PolyPhen-2 0.51
- R16R (p.Arg16Arg), gnomAD X-111410351-C-T, CADD 12.60
- R16W (p.Arg16Trp), gnomAD X-111410353-T-A, CADD 28.70, PolyPhen-2 0.99
- N17S (p.Asn17Ser), NCI-TCGA Cosmic COSV5756, cosmic curated COSV57567, Variant assessed as somatic; moderate impact.
- M18I (p.Met18Ile), cosmic curated COSV57574
- R19* (p.Arg19Ter), rs587783564, ClinGen CA172001, ClinVar RCV000145861, Ensembl rs587783564, Pathogenic
- R19Q (p.Arg19Gln), NCI-TCGA Cosmic COSV5756, cosmic curated COSV57568, gnomAD rs1928603936, CADD 23.60, PolyPhen-2 0.04, Uncertain significance, not provided
- G20A (p.Gly20Ala), cosmic curated COSV10817, CADD 20.40, PolyPhen-2 0.03
- G20C (p.Gly20Cys), TOPMed rs1401318188, gnomAD rs1401318188, CADD 25.80, Uncertain significance, Inborn genetic diseases
- G20V (p.Gly20Val), cosmic curated COSV10968
- R22L (p.Arg22Leu), cosmic curated COSV10057
- R22Q (p.Arg22Gln), rs866795080, ClinGen CA334420949, NCI-TCGA Cosmic COSV1005, AlphaMissense 0.55, MetaLR 0.18, Uncertain significance, not provided
- R22W (p.Arg22Trp), rs1928603116, ClinGen CA414247197, NCI-TCGA Cosmic COSV5756, cosmic curated COSV57569, CADD 25.50, PolyPhen-2 0.98, Uncertain significance, not provided
- M23I (p.Met23Ile), NCI-TCGA Cosmic COSV5757, cosmic curated COSV57575, Variant assessed as somatic; moderate impact.
- G25R (p.Gly25Arg), gnomAD X-111410326-C-T, CADD 24.30, PolyPhen-2 0.98
- L26F (p.Leu26Phe), cosmic curated COSV10523
- P27L (p.Pro27Leu), 1000Genomes rs755495865, TOPMed rs755495865, CADD 23.20
- P27R (p.Pro27Arg), 1000Genomes rs755495865, TOPMed rs755495865
- P27T (p.Pro27Thr), NCI-TCGA Cosmic COSV5757, cosmic curated COSV57575, Variant assessed as somatic; moderate impact.
- S28I (p.Ser28Ile), cosmic curated COSV57574
- S28S (p.Ser28Ser), rs762988798, gnomAD X-111410315-G-A, CADD 9.25
- S28G (p.Ser28Gly), gnomAD X-111410317-T-C, CADD 25.30, PolyPhen-2 0.97
- P29P (p.Pro29Pro), rs779726753, gnomAD X-111410312-G-A, CADD 11.30
- T30A (p.Thr30Ala), Ensembl rs2147276661
- T30N (p.Thr30Asn), cosmic curated COSV57567
- T30S (p.Thr30Ser), gnomAD X-111410310-G-C, CADD 20.20, PolyPhen-2 0.04
- H31R (p.His31Arg), gnomAD X-111410307-T-C, CADD 23.30, PolyPhen-2 0.41
- S32C (p.Ser32Cys), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, Variant assessed as somatic; moderate impact.
- S32N (p.Ser32Asn), rs587783593, ClinGen CA172089, ClinVar RCV000145896, Ensembl rs587783593, AlphaMissense 1.00, MetaLR 0.19, Pathogenic, Ectopic tissue
- S32S (p.Ser32Ser), rs148472336, gnomAD X-111410303-G-A, CADD 7.61
- A33T (p.Ala33Thr), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, Variant assessed as somatic; moderate impact.
- A33V (p.Ala33Val), Ensembl rs1928599232
- A33A (p.Ala33Ala), gnomAD X-111410300-G-C, CADD 11.60
- H34Q (p.His34Gln), cosmic curated COSV57571
- H34H (p.His34His), gnomAD X-111410297-G-A, CADD 8.89
- C35* (p.Cys35Ter), NCI-TCGA Cosmic COSV5757, cosmic curated COSV57576, Variant assessed as somatic; high impact.
- C35R (p.Cys35Arg), rs945410935, ClinGen CA414247110, ClinVar RCV002300968, ClinVar RCV003097878, AlphaMissense 0.95, MetaLR 0.12, Uncertain significance, Inborn genetic diseases; not provided
- C35S (p.Cys35Ser), Ensembl rs945410935
- S36G (p.Ser36Gly), gnomAD X-111410293-T-C, CADD 25.80, PolyPhen-2 0.90
- F37V (p.Phe37Val), Ensembl rs1928598242
- R39* (p.Arg39Ter), rs587783519, ClinGen CA171846, NCI-TCGA Cosmic COSV5756, NCI-TCGA Cosmic COSV5757, CADD 33.00, Pathogenic
- R39G (p.Arg39Gly), cosmic curated COSV57567
- R39Q (p.Arg39Gln), rs892512121, NCI-TCGA Cosmic COSV5756, cosmic curated COSV57566, Ensembl rs892512121, AlphaMissense 0.99, MetaLR 0.24, Variant assessed as somatic; moderate impact.
- R39R (p.Arg39Arg), gnomAD X-111410282-T-C, CADD 14.80
- T40I (p.Thr40Ile), rs2147276605, ClinGen CA414247071, ClinVar RCV001507542, Ensembl rs2147276605, CADD 26.10, PolyPhen-2 0.94, Uncertain significance, not provided
- T40P (p.Thr40Pro), cosmic curated COSV57568, CADD 26.40, PolyPhen-2 0.96
- T40T (p.Thr40Thr), gnomAD X-111410279-G-A, CADD 11.60
- R41K (p.Arg41Lys), Ensembl rs866395084
- T42I (p.Thr42Ile), UniProt VAR 026022, Pathogenic, in LISX1
- T42T (p.Thr42Thr), gnomAD X-111410273-G-T, CADD 11.60
- L43S (p.Leu43Ser), rs587783521, ClinGen CA171850, ClinVar RCV000145808, UniProt VAR 007819, AlphaMissense 1.00, MetaLR 0.83, Pathogenic, in LISX1
- Q44* (p.Gln44Ter), rs587783522, ClinGen CA171853, ClinVar RCV000145809, Ensembl rs587783522, Pathogenic
- Q44H (p.Gln44His), cosmic curated COSV10968
- A45E (p.Ala45Glu), Ensembl rs1928594421
- A45S (p.Ala45Ser), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, Variant assessed as somatic; moderate impact.
- A45A (p.Ala45Ala), rs1312638300, gnomAD X-111410264-T-C, CADD 10.50
- L46M (p.Leu46Met), gnomAD X-111410263-G-T, CADD 24.50, PolyPhen-2 0.93
- S47R (p.Ser47Arg), rs104894783, ClinGen CA121600, ClinVar RCV000012366, ClinVar RCV000012367, AlphaMissense 0.99, MetaLR 0.15, Conflicting interpretations, DCX-related disorder; not provided
- S47S (p.Ser47Ser), gnomAD X-111410258-A-G, CADD 12.40
- N48D (p.Asn48Asp), TOPMed rs1276278929, gnomAD rs1276278929, CADD 22.00, PolyPhen-2 0.00
- N48K (p.Asn48Lys), gnomAD X-111410255-A-C, CADD 12.90, PolyPhen-2 0.02
- N48H (p.Asn48His), gnomAD X-111410257-T-G, CADD 23.20, PolyPhen-2 0.38
- E49K (p.Glu49Lys), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, Variant assessed as somatic; moderate impact.
- K50N (p.Lys50Asn), rs587783523, ClinGen CA171856, ClinVar RCV000145810, UniProt VAR 026023, AlphaMissense 0.99, MetaLR 0.17, Pathogenic, in SBHX
- K50K (p.Lys50Lys), gnomAD X-111410249-C-T, CADD 9.12
- K51R (p.Lys51Arg), cosmic curated COSV99050
- A52D (p.Ala52Asp), rs1556405160, ClinGen CA414246993, NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, AlphaMissense 1.00, MetaLR 0.21, Uncertain significance, Inborn genetic diseases
- A52S (p.Ala52Ser), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, Variant assessed as somatic; moderate impact.
- K53R (p.Lys53Arg), rs1928591548, ClinGen CA414246986, ClinVar RCV002737903, Ensembl rs1928591548, CADD 22.60, PolyPhen-2 0.03, Uncertain significance, Inborn genetic diseases
- K54M (p.Lys54Met), cosmic curated COSV57576
- K54N (p.Lys54Asn), rs1928591160, ClinGen CA414246976, ClinVar RCV001090399, Ensembl rs1928591160, AlphaMissense 1.00, MetaLR 0.36, Uncertain significance, not provided
- V55L (p.Val55Leu), TOPMed rs1157628930, gnomAD rs1157628930
- R56H (p.Arg56His), NCI-TCGA Cosmic COSV5756, cosmic curated COSV57568, CADD 24.10, PolyPhen-2 0.11, Variant assessed as somatic; moderate impact.
- R56L (p.Arg56Leu), rs587783525, ClinGen CA414246964, ClinVar RCV001200546, Ensembl rs587783525, AlphaMissense 1.00, MetaLR 0.53, Likely pathogenic, not provided
- R56P (p.Arg56Pro), rs587783525, ClinGen CA171860, ClinVar RCV000145812, Ensembl rs587783525, AlphaMissense 1.00, MetaLR 0.53, Likely pathogenic
- F57C (p.Phe57Cys), rs587783526, ClinGen CA171863, ClinVar RCV000145813, Ensembl rs587783526, AlphaMissense 1.00, MetaLR 0.57, Likely pathogenic
- F57L (p.Phe57Leu), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, cosmic curated COSV10968, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Y58Y (p.Tyr58Tyr), gnomAD X-111410225-G-A, CADD 10.50
- R59C (p.Arg59Cys), cosmic curated COSV57568
- R59H (p.Arg59His), rs122457137, ClinGen CA171866, NCI-TCGA Cosmic COSV5757, cosmic curated COSV57575, AlphaMissense 1.00, MetaLR 0.93, Pathogenic, in SBHX
- R59L (p.Arg59Leu), rs122457137, ClinGen CA121596, ClinVar RCV000012362, ClinVar RCV000012363, AlphaMissense 1.00, MetaLR 0.93, Pathogenic, Subcortical laminar heterotopia, X-linked; Lissencephaly type 1 due to doublecor
- N60D (p.Asn60Asp), UniProt VAR 026024, Pathogenic, in LISX1
- N60N (p.Asn60Asn), gnomAD X-111410219-A-G, CADD 12.90
- N60S (p.Asn60Ser), gnomAD X-111410220-T-C, CADD 25.30, PolyPhen-2 1.00
- G61E (p.Gly61Glu), rs587783527, ClinGen CA171869, ClinVar RCV000145815, Ensembl rs587783527, AlphaMissense 1.00, MetaLR 0.95, Pathogenic
- G61G (p.Gly61Gly), gnomAD X-111410216-C-T, CADD 13.20
- D62E (p.Asp62Glu), cosmic curated COSV57568
- D62G (p.Asp62Gly), rs587783528, ClinGen CA171872, ClinVar RCV000145816, Ensembl rs587783528, AlphaMissense 1.00, MetaLR 0.63, Likely pathogenic, in LISX1 and SBHX
- D62N (p.Asp62Asn), rs104894779, ClinGen CA121589, NCI-TCGA Cosmic COSV5756, cosmic curated COSV57568, AlphaMissense 1.00, MetaLR 0.94, Pathogenic/Likely pathogenic, Lissencephaly type 1 due to doublecortin gene mutation
- R63C (p.Arg63Cys), rs587783529, ClinGen CA171875, NCI-TCGA Cosmic COSV5757, cosmic curated COSV57571, AlphaMissense 0.94, MetaLR 0.92, Likely pathogenic
- R63H (p.Arg63His), rs1230386660, NCI-TCGA Cosmic COSV5757, cosmic curated COSV57572, gnomAD rs1230386660, AlphaMissense 0.86, MetaLR 0.90, Variant assessed as somatic; moderate impact.
- R63S (p.Arg63Ser), cosmic curated COSV57574
- Y64* (p.Tyr64Ter), rs764964209, ClinGen CA414246914, ClinVar RCV000579102, ExAC rs764964209, Pathogenic
- Y64C (p.Tyr64Cys), rs587783530, ClinGen CA171878, ClinVar RCV000145818, Ensembl rs587783530, AlphaMissense 0.98, MetaLR 0.91, Likely pathogenic
- Y64D (p.Tyr64Asp), rs1556405129, ClinGen CA414246918, ClinVar RCV003685084, AlphaMissense 0.99, MetaLR 0.83, Pathogenic, not provided
- Y64N (p.Tyr64Asn), rs1556405129, ClinGen CA414246919, ClinVar RCV000656086, Ensembl rs1556405129, AlphaMissense 0.99, MetaLR 0.83, Likely pathogenic, Lissencephaly type 1 due to doublecortin gene mutation
- Y64Y (p.Tyr64Tyr), rs764964209, gnomAD X-111410207-G-A, CADD 12.00
- F65L (p.Phe65Leu), rs587783531, ClinGen CA171881, cosmic curated COSV57566, ClinVar RCV000145819, AlphaMissense 1.00, MetaLR 0.63, Likely pathogenic
- F65Y (p.Phe65Tyr), cosmic curated COSV57569
- F65F (p.Phe65Phe), rs587783531, gnomAD X-111410204-G-A, AlphaMissense 1.00, MetaLR 0.63
- G67E (p.Gly67Glu), UniProt VAR 026025, Pathogenic, not provided
- G67W (p.Gly67Trp), cosmic curated COSV57568
- G67G (p.Gly67Gly), rs760929190, gnomAD X-111410198-C-G, CADD 10.80
- I68M (p.Ile68Met), ExAC rs773349250, gnomAD rs773349250
- I68F (p.Ile68Phe), gnomAD X-111410197-T-A, CADD 24.40, PolyPhen-2 0.34
- V69L (p.Val69Leu), cosmic curated COSV10742
- V69M (p.Val69Met), NCI-TCGA Cosmic COSV5756, cosmic curated COSV57568, Variant assessed as somatic; moderate impact.
- Y70* (p.Tyr70Ter), rs587783532, ClinGen CA171884, cosmic curated COSV57570, ClinVar RCV000145820, Pathogenic
- Y70C (p.Tyr70Cys), NCI-TCGA Cosmic COSV5757, cosmic curated COSV57570, Ensembl rs2147276399, CADD 27.80, PolyPhen-2 0.98, Variant assessed as somatic; moderate impact.
- Y70Y (p.Tyr70Tyr), gnomAD X-111410189-G-A, CADD 8.34
- Y70H (p.Tyr70His), gnomAD X-111410191-A-G, CADD 27.00, PolyPhen-2 0.98
- A71D (p.Ala71Asp), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, NCI-TCGA Cosmic COSV5757, Ensembl rs2147276379, Variant assessed as somatic; moderate impact., in LISX1
- A71P (p.Ala71Pro), cosmic curated COSV57573
- A71S (p.Ala71Ser), rs104894786, ClinGen CA121609, ClinVar RCV000012375, ClinVar RCV000012376, AlphaMissense 0.91, MetaLR 0.90, Pathogenic, Subcortical laminar heterotopia, X-linked; Lissencephaly type 1 due to doublecor
- A71T (p.Ala71Thr), rs104894786, ClinGen CA414246873, NCI-TCGA Cosmic COSV5757, ClinVar RCV001030995, AlphaMissense 0.91, MetaLR 0.90, Conflicting interpretations, not provided; Lissencephaly type 1 due to doublecortin gene mutation; Inborn gen
- A71V (p.Ala71Val), cosmic curated COSV57573
- A71A (p.Ala71Ala), gnomAD X-111410186-A-G, CADD 13.50
- S73F (p.Ser73Phe), rs587783533, ClinGen CA171887, ClinVar RCV000145821, Ensembl rs587783533, AlphaMissense 0.99, MetaLR 0.92, Pathogenic
- S74C (p.Ser74Cys), cosmic curated COSV57574
- D75N (p.Asp75Asn), NCI-TCGA Cosmic COSV5756, cosmic curated COSV57569, Variant assessed as somatic; moderate impact.
- R76C (p.Arg76Cys), rs587783534, ClinGen CA171890, ClinVar RCV000145822, ClinVar RCV002470773, AlphaMissense 1.00, MetaLR 0.84, Pathogenic
- R76G (p.Arg76Gly), rs587783534, ClinGen CA414246842, ClinVar RCV000760181, gnomAD rs587783534, AlphaMissense 1.00, MetaLR 0.84, Pathogenic, Lissencephaly type 1 due to doublecortin gene mutation
- R76H (p.Arg76His), NCI-TCGA Cosmic COSV5756, cosmic curated COSV57566, Variant assessed as somatic; moderate impact.
- R76S (p.Arg76Ser), gnomAD rs587783534, AlphaMissense 1.00, MetaLR 0.84, Pathogenic
- R78C (p.Arg78Cys), rs587783535, ClinGen CA171893, NCI-TCGA Cosmic COSV5757, cosmic curated COSV57570, AlphaMissense 0.98, MetaLR 0.90, Pathogenic, in SBHX
- R78H (p.Arg78His), rs104894784, ClinGen CA121602, NCI-TCGA Cosmic COSV5757, cosmic curated COSV57572, AlphaMissense 0.96, MetaLR 0.91, Pathogenic, not provided
- R78L (p.Arg78Leu), rs104894784, ClinGen CA171896, ClinVar RCV000145824, ClinVar RCV001291058, AlphaMissense 0.96, MetaLR 0.91, Pathogenic, in SBHX
- S79N (p.Ser79Asn), cosmic curated COSV57567
- D81* (p.Asp81Ter), rs2147276330, ClinGen CA2573055070, ClinVar RCV001814326, Pathogenic
- D81H (p.Asp81His), Ensembl rs1928578940
- D81N (p.Asp81Asn), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, Variant assessed as somatic; moderate impact.
- D81D (p.Asp81Asp), rs1928578527, gnomAD X-111410156-G-A, CADD 0.62
- A82T (p.Ala82Thr), rs1305044719, NCI-TCGA Cosmic COSV5757, cosmic curated COSV57573, gnomAD rs1305044719, CADD 22.90, PolyPhen-2 0.36, Variant assessed as somatic; moderate impact.
- A82V (p.Ala82Val), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, Variant assessed as somatic; moderate impact.
- L84L (p.Leu84Leu), rs936797200, gnomAD X-111410149-G-A, CADD 9.77
- D86H (p.Asp86His), UniProt VAR 007825, Pathogenic, in SBHX
- D86N (p.Asp86Asn), NCI-TCGA Cosmic COSV5756, cosmic curated COSV57566, Variant assessed as somatic; moderate impact., in SBHX
- T88K (p.Thr88Lys), cosmic curated COSV10523
- T88M (p.Thr88Met), rs2147276286, ClinGen CA414246762, ClinVar RCV003129346, NCI-TCGA Cosmic COSV5757, AlphaMissense 1.00, MetaLR 0.95, Conflicting interpretations, not provided
- T88R (p.Thr88Arg), rs2147276286, ClinGen CA414246763, ClinVar RCV001922327, Ensembl rs2147276286, AlphaMissense 1.00, MetaLR 0.95, Uncertain significance, not provided
- T88T (p.Thr88Thr), gnomAD X-111410135-C-T, CADD 5.74
- R89* (p.Arg89Ter), rs104894785, ClinGen CA171899, NCI-TCGA Cosmic COSV5756, cosmic curated COSV57565, AlphaMissense 0.97, MetaLR 0.86, Pathogenic, in SBHX
- R89G (p.Arg89Gly), rs104894785, ClinGen CA121604, ClinVar RCV000012372, UniProt VAR 010536, AlphaMissense 0.97, MetaLR 0.86, Pathogenic, Subcortical laminar heterotopia, X-linked
- R89P (p.Arg89Pro), rs61729440, ClinGen CA171902, ClinVar RCV000145826, Ensembl rs61729440, AlphaMissense 1.00, MetaLR 0.90, Pathogenic, in SBHX
- R89Q (p.Arg89Gln), rs61729440, ClinGen CA414246760, NCI-TCGA Cosmic COSV5757, cosmic curated COSV57571, AlphaMissense 1.00, MetaLR 0.90, Pathogenic, Lissencephaly type 1 due to doublecortin gene mutation
- L91P (p.Leu91Pro), rs587783536, ClinGen CA171905, ClinVar RCV000145827, Ensembl rs587783536, AlphaMissense 1.00, MetaLR 0.94, Pathogenic
- L91L (p.Leu91Leu), gnomAD X-111410126-C-G, CADD 10.30
- S92F (p.Ser92Phe), cosmic curated COSV57567
- N94D (p.Asn94Asp), rs797045512, ClinGen CA205961, ClinVar RCV000192850, ClinVar RCV001542722, AlphaMissense 0.67, MetaLR 0.87, Pathogenic, Abnormal cortical gyration
- N94N (p.Asn94Asn), gnomAD X-111410117-G-A, CADD 10.60
- I95I (p.Ile95Ile), gnomAD X-111410114-G-T, CADD 11.10
- N96K (p.Asn96Lys), rs1556405057, ClinGen CA414246714, ClinVar RCV000625954, Ensembl rs1556405057, AlphaMissense 0.99, MetaLR 0.26, Likely pathogenic, Fucosidosis
- L97R (p.Leu97Arg), rs587783537, ClinGen CA171908, ClinVar RCV000145828, UniProt VAR 026027, AlphaMissense 1.00, MetaLR 0.94, Pathogenic, in SBHX
- L97V (p.Leu97Val), rs1928574753, ClinGen CA414246711, ClinVar RCV001291057, Ensembl rs1928574753, AlphaMissense 0.97, MetaLR 0.94, Likely pathogenic, Lissencephaly
- Q99L (p.Gln99Leu), NCI-TCGA Cosmic COSV1005, cosmic curated COSV10057, Variant assessed as somatic; moderate impact.
- Q99Q (p.Gln99Gln), gnomAD X-111410102-C-T, CADD 10.00
- G100A (p.Gly100Ala), UniProt VAR 007826, Pathogenic, in LISX1 and SBHX
- G100E (p.Gly100Glu), rs587783538, ClinGen CA171911, ClinVar RCV000145829, Ensembl rs587783538, AlphaMissense 1.00, MetaLR 0.97, Pathogenic, in LISX1 and SBHX
- G100R (p.Gly100Arg), rs2524858685, ClinGen CA414246693, ClinVar RCV002290137, cosmic curated COSV57571, Uncertain significance, not provided
Public DCX analysis runs
- DCX analysis run — DCX (668 variants) — completed 2026-08-22